In a search for Polo-like kinase 1 (Plk1) interaction proteins, we have identified TRF1 (telomeric repeat binding factor 1) as a potential Plk1 target. In this communication we report further characterization of the interaction. We show that Plk1 associates with TRF1, and Plk1 phosphorylates TRF1 at Ser-435 in vivo. Moreover, Cdk1, serving as a priming kinase, phosphorylates TRF1 to generate a docking site for Plk1 toward TRF1. In the presence of nocodazole, ectopic expression of wild type TRF1 but not TRF1 with alanine mutation in the Plk1 phosphorylation site induces apoptosis in cells containing short telomeres but not in cells containing long telomeres. Unexpectedly, down-regulation of TRF1 by RNA interference affects cell proliferation and results in obvious apoptosis in cells with short telomeres but not in cells with long telomeres. Importantly, we observe that telomeric DNA binding ability of TRF1 is cell cycleregulated and reaches a peak during mitosis. Upon phosphorylation by Plk1 in vivo and in vitro, the ability of TRF1 to bind telomeric DNA is dramatically increased. These results demonstrate that Plk1 interacts with and phosphorylates TRF1 and suggest that Plk1-mediated phosphorylation is involved in both TRF1 overexpression-induced apoptosis and its telomeric DNA binding ability.Composed of repetitive DNA sequences of TTAGGG arrays (in vertebrates) and telomere-binding proteins (1), telomeres are specialized DNA structures positioned at the termini of eukaryotic chromosomes (2). Telomeric DNA together with specific and nonspecific telomere-binding proteins participates in forming highly ordered structures that protect the ends of chromosomes from exonucleolytic attack, end-to-end fusion, and degradation leading to cell death, possible genetic recombination, or survival selection (1, 3, 4). Most human normal somatic cells show a progressive loss of telomeric DNA during successive rounds of cell division due to incomplete DNA replication at the most terminal lagging-strand synthesis (4, 5). Thus, telomere shortening functions as a control mechanism that regulates the replicative capacity of cells and cellular senescence (6). Telomeres are regulated by a homeostatic mechanism that includes telomerase, a reverse transcriptase that adds telomeric TTAGGG repeats onto the 3Ј end of chromosomes (7,8), and telomeric repeat-binding proteins, TRF12 and TRF2, both of which share the highly conserved Myb-like telomeric DNA binding domain. Although the TRF1 complex contains TRF1, TRF1 interacting partners, TIN2, TPP1, and POT1, the TRF2 complex contains TRF2 and its interacting partner RAP1 (1, 4). TRF1 has been shown to negatively regulate telomere length. Overexpression of TRF1 accelerates telomere shortening, whereas dominant-negative inhibition of TRF1 leads to telomere elongation (9). TRF2, a distant homologue of TRF1, also binds to telomeric DNA as a homodimer through the Myblike domain (10). TRF2 is required to protect chromosomal ends (van Steensel et al. (12)) by stabilizing a terminal loop structure c...